The facility is the result of a landmark multi-million-pound collaboration between the University of Oxford, OSCAR and Prenetics Limited, a global leader in the field of diagnostics and genetic testing.
Together, they intend to develop affordable, decentralized and point-of-care tests for infectious diseases threatening global health, including Covid-19.
OSCAR opened in 2018 as the University’s first overseas centre for physical science and engineering research. Its research programmes are led by University of Oxford academics, and range from health informatics, tissue engineering and biomedical imaging techniques to environmental remediation, advanced materials and electronic devices.